DOCSLIB.ORG

PCT Gazette, Weekly Issue No. 26, 2001

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PCT Gazette, Weekly Issue No. 26, 2001 26/2001 28 Jun/juin 2001 PCT Gazette - Section III - Gazette du PCT 11311 SECTION III WEEKLY INDEXES INDEX HEBDOMADAIRES INTERNATIONAL APPLICATION NUMBERS AND CORRESPONDING INTERNATIONAL PUBLICATION NUMBERS NUMÉROS DES DEMANDES INTERNATIONALES ET NUMÉROS DE PUBLICATION INTERNATIONALE CORRESPONDANTS International International International International International International Application Publication Application Publication Application Publication Numbers Numbers Numbers Numbers Numbers Numbers Numéros des Numéros de Numéros des Numéros de Numéros des Numéros de demandes publication demandes publication demandes publication internationales internationale internationales internationale internationales internationale AT CA CN PCT/AT00/00322 WO 01/46075 PCT/CA00/01510 WO 01/47091 PCT/CN00/00568 WO 01/46250 PCT/AT00/00334 WO 01/46081 PCT/CA00/01513 WO 01/46694 PCT/CN00/00569 WO 01/46431 PCT/AT00/00341 WO 01/45810 PCT/CA00/01516 WO 01/46691 PCT/CN00/00570 WO 01/46235 PCT/AT00/00342 WO 01/45811 PCT/CA00/01517 WO 01/45732 PCT/CN00/00582 WO 01/46439 PCT/AT00/00350 WO 01/46676 PCT/CA00/01519 WO 01/47124 PCT/CN00/00583 WO 01/46236 PCT/AT00/00351 WO 01/46656 PCT/CA00/01529 WO 01/46876 PCT/CN00/00584 WO 01/46440 PCT/CA00/01534 WO 01/46224 PCT/CN00/00585 WO 01/46237 AU PCT/CA00/01535 WO 01/46225 PCT/CN00/00587 WO 01/46238 PCT/AU99/01147 WO 01/45542 PCT/CA00/01536 WO 01/46226 PCT/CN00/00588 WO 01/46432 PCT/AU00/01169 WO 01/45538 PCT/CA00/01542 WO 01/45622 PCT/CN00/00589 WO 01/46441 PCT/AU00/01211 WO 01/45867 PCT/CA00/01543 WO 01/45851 PCT/CN00/00600 WO 01/46239 PCT/AU00/01554 WO 01/46856 PCT/CA00/01545 WO 01/46405 PCT/CN00/00601 WO 01/46240 PCT/AU00/01561 WO 01/46875 PCT/CA00/01547 WO 01/46203 PCT/CN00/00602 WO 01/46251 PCT/AU00/01567 WO 01/45850 PCT/CA00/01548 WO 01/46204 PCT/CN00/00603 WO 01/45729 PCT/AU00/01571 WO 01/46561 PCT/CA00/01549 WO 01/46205 PCT/CN00/00604 WO 01/46252 PCT/AU00/01572 WO 01/46010 PCT/CA00/01550 WO 01/46206 PCT/CN00/00605 WO 01/46253 PCT/AU00/01573 WO 01/47263 PCT/CA00/01553 WO 01/47050 PCT/CN00/00606 WO 01/46241 PCT/AU00/01575 WO 01/45971 PCT/CA00/01555 WO 01/45915 PCT/CN00/00607 WO 01/46433 PCT/AU00/01583 WO 01/46558 PCT/CA00/01557 WO 01/45709 PCT/CN00/00608 WO 01/46442 PCT/AU00/01584 WO 01/46625 PCT/CA00/01558 WO 01/46166 PCT/CN00/00609 WO 01/46435 PCT/AU00/01590 WO 01/46915 PCT/CA00/01559 WO 01/46151 PCT/CN00/00643 WO 01/47046 PCT/AU00/01593 WO 01/45626 PCT/CA00/01563 WO 01/46671 PCT/AU00/01598 WO 01/46115 PCT/CA00/01566 WO 01/46596 CZ PCT/AU00/01600 WO 01/46526 PCT/CA00/01567 WO 01/46594 PCT/CZ00/00081 WO 01/46005 PCT/AU00/01602 WO 01/45854 PCT/CA00/01582 WO 01/46857 PCT/AU00/01603 WO 01/45718 DE PCT/AU00/01611 WO 01/46459 CH PCT/DE99/04042 WO 01/47019 PCT/CH99/00612 WO 01/45576 PCT/DE00/02601 WO 01/47331 BE PCT/CH99/00618 WO 01/46936 PCT/DE00/03845 WO 01/45520 PCT/BE00/00148 WO 01/46006 PCT/CH00/00631 WO 01/46528 PCT/DE00/03872 WO 01/46046 PCT/BE00/00150 WO 01/45762 PCT/CH00/00653 WO 01/46033 PCT/DE00/03938 WO 01/47160 PCT/BE00/00151 WO 01/46444 PCT/CH00/00669 WO 01/46640 PCT/DE00/04081 WO 01/47139 PCT/BE00/00152 WO 01/45760 PCT/CH00/00672 WO 01/46227 PCT/DE00/04084 WO 01/45908 PCT/BE00/00153 WO 01/46389 PCT/CH00/00676 WO 01/46641 PCT/DE00/04150 WO 01/46703 PCT/DE00/04180 WO 01/45596 BR CN PCT/DE00/04189 WO 01/47062 PCT/BR00/00111 WO 01/46269 PCT/CN00/00541 WO 01/46425 PCT/DE00/04219 WO 01/46692 PCT/BR00/00124 WO 01/46633 PCT/CN00/00542 WO 01/46429 PCT/DE00/04220 WO 01/46920 PCT/BR00/00141 WO 01/46588 PCT/CN00/00543 WO 01/46242 PCT/DE00/04291 WO 01/45946 PCT/BR00/00143 WO 01/46297 PCT/CN00/00544 WO 01/46243 PCT/DE00/04315 WO 01/46973 PCT/BR00/00144 WO 01/47094 PCT/CN00/00545 WO 01/46409 PCT/DE00/04318 WO 01/46565 PCT/BR00/00147 WO 01/46661 PCT/CN00/00546 WO 01/46437 PCT/DE00/04361 WO 01/47092 PCT/BR00/00160 WO 01/46216 PCT/CN00/00548 WO 01/46257 PCT/DE00/04362 WO 01/47067 PCT/BR00/00161 WO 01/46217 PCT/CN00/00549 WO 01/46244 PCT/DE00/04373 WO 01/46566 PCT/BR00/00162 WO 01/46337 PCT/CN00/00550 WO 01/46410 PCT/DE00/04398 WO 01/47131 PCT/CN00/00551 WO 01/46411 PCT/DE00/04401 WO 01/47068 CA PCT/CN00/00552 WO 01/46424 PCT/DE00/04402 WO 01/47221 PCT/CA99/01240 WO 01/45608 PCT/CN00/00553 WO 01/46245 PCT/DE00/04429 WO 01/46682 PCT/CA00/00958 WO 01/46760 PCT/CN00/00555 WO 01/46426 PCT/DE00/04442 WO 01/46763 PCT/CA00/01399 WO 01/46270 PCT/CN00/00556 WO 01/46427 PCT/DE00/04454 WO 01/46066 PCT/CA00/01454 WO 01/47100 PCT/CN00/00557 WO 01/46246 PCT/DE00/04459 WO 01/46764 PCT/CA00/01461 WO 01/45829 PCT/CN00/00559 WO 01/46247 PCT/DE00/04473 WO 01/45827 PCT/CA00/01473 WO 01/46073 PCT/CN00/00560 WO 01/46430 PCT/DE00/04475 WO 01/47040 PCT/CA00/01482 WO 01/45816 PCT/CN00/00563 WO 01/46248 PCT/DE00/04514 WO 01/45914 PCT/CA00/01499 WO 01/47264 PCT/CN00/00565 WO 01/46438 PCT/DE00/04517 WO 01/46951 PCT/CA00/01505 WO 01/46944 PCT/CN00/00566 WO 01/46234 PCT/DE00/04518 WO 01/46582 PCT/CA00/01509 WO 01/46014 PCT/CN00/00567 WO 01/46249 PCT/DE00/04519 WO 01/46583 26/2001 11312 PCT Gazette - Section III - Gazette du PCT 28 Jun/juin 2001 International Application Numbers and Corresponding International Publication Numbers (Continued) Numéros des demandes internationales et numéros de publication internationale correspondants (Suite) International International International International International International Application Publication Application Publication Application Publication Numbers Numbers Numbers Numbers Numbers Numbers Numéros des Numéros de Numéros des Numéros de Numéros des Numéros de demandes publication demandes publication demandes publication internationales internationale internationales internationale internationales internationale DE EP EP PCT/DE00/04522 WO 01/47140 PCT/EP00/11794 WO 01/46369 PCT/EP00/12508 WO 01/47109 PCT/DE00/04523 WO 01/47101 PCT/EP00/11863 WO 01/46604 PCT/EP00/12510 WO 01/46271 PCT/DE00/04530 WO 01/47180 PCT/EP00/11879 WO 01/46976 PCT/EP00/12511 WO 01/46274 PCT/DE00/04531 WO 01/47056 PCT/EP00/11881 WO 01/46292 PCT/EP00/12514 WO 01/46094 PCT/DE00/04532 WO 01/47219 PCT/EP00/11928 WO 01/45893 PCT/EP00/12515 WO 01/46141 PCT/DE00/04535 WO 01/47309 PCT/EP00/11932 WO 01/46724 PCT/EP00/12516 WO 01/46317 PCT/DE00/04537 WO 01/46654 PCT/EP00/11934 WO 01/47311 PCT/EP00/12520 WO 01/45661 PCT/DE00/04556 WO 01/46579 PCT/EP00/11959 WO 01/46285 PCT/EP00/12522 WO 01/45909 PCT/DE00/04557 WO 01/46412 PCT/EP00/11992 WO 01/46498 PCT/EP00/12524 WO 01/45562 PCT/DE00/04565 WO 01/46533 PCT/EP00/12053 WO 01/46293 PCT/EP00/12527 WO 01/47255 PCT/DE00/04573 WO 01/47141 PCT/EP00/12106 WO 01/46926 PCT/EP00/12529 WO 01/46356 PCT/DE00/04574 WO 01/46576 PCT/EP00/12139 WO 01/46994 PCT/EP00/12530 WO 01/46514 PCT/DE00/04576 WO 01/47334 PCT/EP00/12145 WO 01/46995 PCT/EP00/12531 WO 01/46364 PCT/DE00/04577 WO 01/45947 PCT/EP00/12188 WO 01/46286 PCT/EP00/12532 WO 01/46357 PCT/DE00/04581 WO 01/46739 PCT/EP00/12219 WO 01/46735 PCT/EP00/12539 WO 01/47300 PCT/DE00/04583 WO 01/45755 PCT/EP00/12223 WO 01/47030 PCT/EP00/12540 WO 01/47325 PCT/DE00/04585 WO 01/46460 PCT/EP00/12228 WO 01/46509 PCT/EP00/12550 WO 01/46563 PCT/DE00/04599 WO 01/46087 PCT/EP00/12234 WO 01/45720 PCT/EP00/12554 WO 01/45880 PCT/DE00/04603 WO 01/46719 PCT/EP00/12238 WO 01/46363 PCT/EP00/12570 WO 01/45712 PCT/DE00/04606 WO 01/47289 PCT/EP00/12245 WO 01/47024 PCT/EP00/12578 WO 01/46139 PCT/DE00/04621 WO 01/45972 PCT/EP00/12247 WO 01/47274 PCT/EP00/12579 WO 01/45505 PCT/EP00/12252 WO 01/46768 PCT/EP00/12580 WO 01/46379 DK PCT/EP00/12254 WO 01/47290 PCT/EP00/12581 WO 01/46377 PCT/DK00/00697 WO 01/45595 PCT/EP00/12255 WO 01/47027 PCT/EP00/12582 WO 01/46358 PCT/DK00/00703 WO 01/45964 PCT/EP00/12256 WO 01/47125 PCT/EP00/12591 WO 01/46122 PCT/DK00/00705 WO 01/46560 PCT/EP00/12257 WO 01/47129 PCT/EP00/12602 WO 01/45892 PCT/DK00/00706 WO 01/45997 PCT/EP00/12258 WO 01/46948 PCT/EP00/12610 WO 01/47306 PCT/DK00/00707 WO 01/47099 PCT/EP00/12262 WO 01/46709 PCT/EP00/12615 WO 01/45968 PCT/DK00/00713 WO 01/46453 PCT/EP00/12322 WO 01/46153 PCT/EP00/12621 WO 01/47324 PCT/DK00/00715 WO 01/47070 PCT/EP00/12323 WO 01/46105 PCT/EP00/12622 WO 01/47323 PCT/DK00/00722 WO 01/45815 PCT/EP00/12324 WO 01/46104 PCT/EP00/12635 WO 01/45948 PCT/DK00/00723 WO 01/47173 PCT/EP00/12325 WO 01/46100 PCT/EP00/12636 WO 01/45944 PCT/DK01/00147 WO 01/45483 PCT/EP00/12328 WO 01/47032 PCT/EP00/12637 WO 01/46606 PCT/EP00/12341 WO 01/47272 PCT/EP00/12639 WO 01/46599 EP PCT/EP00/12356 WO 01/46809 PCT/EP00/12640 WO 01/46163 PCT/EP99/10146 WO 01/47228 PCT/EP00/12359 WO 01/45923 PCT/EP00/12643 WO 01/46445 PCT/EP99/10271 WO 01/47069 PCT/EP00/12372 WO 01/46375 PCT/EP00/12650 WO 01/45650 PCT/EP99/10313 WO 01/46744 PCT/EP00/12373 WO 01/46983 PCT/EP00/12651 WO 01/45652 PCT/EP99/10328 WO 01/45534 PCT/EP00/12377 WO 01/47154 PCT/EP00/12652 WO 01/46452 PCT/EP00/04637 WO 01/45849 PCT/EP00/12378 WO 01/47258 PCT/EP00/12653 WO 01/45662 PCT/EP00/08201 WO 01/46592 PCT/EP00/12379 WO 01/47247 PCT/EP00/12654 WO 01/46088 PCT/EP00/10191 WO 01/46536 PCT/EP00/12380 WO 01/47017 PCT/EP00/12655 WO 01/45666 PCT/EP00/10451 WO 01/46504 PCT/EP00/12381 WO 01/47126 PCT/EP00/12656 WO 01/45659 PCT/EP00/10597 WO 01/46904 PCT/EP00/12382 WO 01/47265 PCT/EP00/12657 WO 01/45646 PCT/EP00/10691 WO 01/45894 PCT/EP00/12383 WO 01/47266 PCT/EP00/12658 WO 01/45658 PCT/EP00/10760 WO 01/46632 PCT/EP00/12384 WO 01/47105 PCT/EP00/12659 WO 01/46330 PCT/EP00/10762 WO 01/46631 PCT/EP00/12387 WO 01/47106 PCT/EP00/12666 WO 01/47245 PCT/EP00/10763 WO 01/46630 PCT/EP00/12397 WO 01/45525 PCT/EP00/12667 WO 01/46167 PCT/EP00/10868 WO 01/46970 PCT/EP00/12403 WO 01/46789 PCT/EP00/12672 WO 01/46664 PCT/EP00/10964 WO 01/46479 PCT/EP00/12404 WO 01/46751 PCT/EP00/12686 WO 01/46077
Load more

Recommended publications
  • Preven Ng Pharmaceu Cal Pollu on and Diversion
    Preven&ng Pharmaceu&cal Pollu&on and Diversion Kate Hagemann & Sierra Fletcher Product Stewardship Ins&tute How to Participate Today • Open and close your Panel • View, Select, and Test your audio • Submit text questions • Raise your hand • Q&A addressed at the end of today’s session • Everyone will receive an email within 24 hours with a link to view a recorded version of today’s session Who is the Product Stewardship Instute? § Non-profit founded in 2000 § Membership ü 47 States ü 200+ Local governments ü 70+ Corporate, Organizaonal, Academic & Non-U.S. Government Partners § Board of Directors: 7 states, 4 local agencies • Mul4-stakeholder product stewardship network 3 The Problem: Waste Pharmaceucals 1. Environmental Concerns 2. Drug Diversion concerns 3. Public Safety Concerns 4 1. Environmental Concerns • Effects in the environment: – Endocrine disruptors – An&bio&c resistance • Pharmaceu&cals enter the environment via a number of channels – Agricultural run-off – Human excre&on – Improper disposal • Current waste water treatment plants cannot remove pharmaceu&cal compounds April 15, 2011 5 Evidence of pharmaceucals In our waterways • Minnesota Pollu&on Control Agency (2011) • USGS (June 2002) •“a broad range of chemicals found in residen3al, industrial, and agricultural wastewaters commonly occurs in mixtures at low concentra3ons downstream from areas of intense urbaniza3on and animal producon. The chemicals include human and veterinary drugs (including an3bio3cs), natural and synthe3c hormones, detergent metabolites, plas3cizers, inseccides, and fire retardants. One or more of these chemicals were found in 80 percent of the streams sampled” April 15, 2011 6 Environmental Impacts • Ecological impacts remain unknown • Observed impacts: – Abnormali&es – Disrupts reproduc&ve systems/risk of ex&ncon • Baylor University researchers found residues human medicaons in fish.
    [Show full text]
  • 38Th Annual Conference
    38th Annual Conference Conference Program Book Sponsored by: November 5-8, 2019 Booth #232 Salt Lake City, Utah Salt Palace Convention Center REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Committed to Patients Powered by Science Driven by Experience Amelia, CLN2 Jason, MPS II Charlie, HoFH Christopher, MPS I Geri, Wet AMD Our investigational gene therapy product candidates are designed to deliver genes to cells to address the genetic defects or to enable cells in the body to produce therapeutic proteins that are intended to impact disease. • 4 clinical stage programs in retinal, metabolic, and neurodegenerative diseases • Proprietary NAV® Technology Platform includes exclusive worldwide rights to over 100 AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10 REGENXBIO.com Welcome to Salt Lake City! n behalf of the National Society of Genetic Counselors (NSGC), the Annual Conference Program Committee and the NSGC Board of O Directors, thank you for joining us! Table of Contents NSGC is excited to bring you education and networking opportunities Conference Information 5 designed to help you elevate the field of genetic counseling. Educational Schedule-at-a-Glance 8 sessions will cover a variety of topics at the forefront of genomics, such as gene editing, polygenic risk scores and artificial intelligence. Convention Center Map 13 Educational highlights you do not want to miss include: 40 years of the Reunion Information 14 Genetic Counseling Profession: A Foundation for the Future, The NSGC and ASHG Joint Session: Genetic Counselors in Research: From Dabbling Session Speakers + Objectives 16 in Clinic to an NIH Grant and the Professional Issues Panel.
    [Show full text]
  • Appendix 2 PCPSA Members Page 1 of 3 Companies Registered with PCPSA in 2008 Page: 2
    Companies registered with PCPSA in 2008 Page: 1 Company PCPSA Categories Registration Date AbbottTotals Laboratories Limited Brand Name November 8, 2006 Abraxis BioScience Inc. Generic December 4, 2006 Actelion Pharmaceuticals Canada Inc. Brand Name April 22, 2005 Advantage CKN Self-care June 22, 2001 Alcon Canada Inc. Brand Name March 7, 2007 Amgen Canada Inc. Brand Name March 9, 2007 Apotex Inc. Generic September 16, 2002 Astellas Pharma Canada Inc. Brand Name November 10, 2006 AstraZeneca Canada Inc. Brand Name December 14, 2001 Au Naturel Canada Inc. Self-care November 14, 2007 Axcan Pharma Inc. Brand Name April 6, 2005 Bayer Inc. Brand Name, Self-care February 5, 2004 Bioforce Canada Inc. Self-care August 27, 2007 Biovail Pharmaceuticals Canada Brand Name Boehringer Ingelheim Canada Ltd. Brand Name, Self-care July 21, 2004 Boiron Canada Inc. Self-care May 9, 2007 Bristol-Myers Squibb Pharmaceutical Group Brand Name, Self-care Canada Safeway Ltd. Self-care November 5, 2007 Chattem (Canada) Inc. Self-care April 23, 2004 Church & Dwight Canada Self-care August 14, 2001 Cobalt Pharmaceuticals Inc. Generic November 15, 2006 Combe Incorporated Self-care December 5, 2006 Costco Self-care CV Technologies Inc. Self-care October 26, 2006 Cytex Pharmaceutical Inc. Generic July 30, 2007 Eli Lilly Canada Inc. Brand Name September 9, 2001 EMD-Serono Canada Inc. Brand Name October 1, 2008 Enzymatic Therapy Self-care Ferring Inc. Brand Name Gaia Garden Herbals Inc. Self-care Galderma Canada Brand Name September 14, 2004 General Nutrition Centres Canada Self-care March 20, 2008 GenPharm Inc. Generic GlaxoSmithKline Consumer Healthcare Self-care August 30, 2001 GlaxoSmithKline Inc.
    [Show full text]
  • PCT Gazette, Weekly Issue No. 13, 2004
    13/2004 25 Mar/mar 2004 PCT Gazette - Section III - Gazette du PCT 7007 SECTION III WEEKLY INDEXES INDEX HEBDOMADAIRES INTERNATIONAL APPLICATION NUMBERS AND CORRESPONDING INTERNATIONAL PUBLICATION NUMBERS NUMÉROS DES DEMANDES INTERNATIONALES ET NUMÉROS DE PUBLICATION INTERNATIONALE CORRESPONDANTS International International International International International International Application Publication Application Publication Application Publication Numbers Numbers Numbers Numbers Numbers Numbers Numéros des Numéros de Numéros des Numéros de Numéros des Numéros de demandes publication demandes publication demandes publication internationales internationale internationales internationale internationales internationale AT BR CN PCT/AT2003/000079 WO 2004/025168 PCT/BR2003/000128 WO 2004/024058 PCT/CN2002/000705 WO 2004/025192 PCT/AT2003/000258 WO 2004/025667 PCT/CN2002/000801 WO 2004/024847 PCT/AT2003/000259 WO 2004/023943 CA PCT/CN2002/000879 WO 2004/025180 PCT/AT2003/000263 WO 2004/024605 PCT/CA2002/001381 WO 2004/024962 PCT/CN2003/000109 WO 2004/025932 PCT/AT2003/000265 WO 2004/023919 PCT/CA2002/001393 WO 2004/024545 PCT/CN2003/000198 WO 2004/025681 PCT/AT2003/000266 WO 2004/025573 PCT/CA2003/000362 WO 2004/024553 PCT/CN2003/000252 WO 2004/025605 PCT/AT2003/000267 WO 2004/025574 PCT/CA2003/001152 WO 2004/024412 PCT/CN2003/000278 WO 2004/025064 PCT/AT2003/000271 WO 2004/024020 PCT/CA2003/001187 WO 2004/024574 PCT/CN2003/000500 WO 2004/024724 PCT/AT2003/000272 WO 2004/024529 PCT/CA2003/001290 WO 2004/024419 PCT/CN2003/000502 WO 2004/024678
    [Show full text]
  • Product Stewardship Financing Models: a Look at the Post-Consumer Product Stewardship Association
    Product Stewardship Financing Models: A Look at the Post-Consumer Product Stewardship Association Type of Brand-owner funded take-back program (mandatory in BC and Manitoba). Program: Pharmaceuticals and natural health products, including prescription drugs, nonprescription Scope: medicines and natural health products such as herbal products, mineral and vitamin supplements (accepted in household quantities). In 1997, the B.C. Waste Management Act – Post Consumer Residual Stewardship, required all Status: brand-owners of pharmaceutical products to be responsible for their products’ end-of-life disposal. Starting in 2000, PCPSA began managing the stewardship plan with the Medications Return Program. The Recycling Regulation (B.C. Reg 449/2004) has now replaced the previous regulation. Overview Unused medications are a health and safety hazard when stored in patients’ homes. They can also damage the natural environment when incorrectly used or disposed of. The Post-Consumer Pharmaceutical Stewardship Association (PCPSA) is a non-profit organization that directly administers the Medications Return Program through funding from pharmaceutical and consumer health products members. PCPSA was established by the industry to comply with British Columbia’s Waste Management Act, a law intended to reduce the environmental and public health risks associated with consumer goods, including leftover medications. The act requires producers to establish a system to safely collect and dispose of the public’s unused medications. PCPSA has been successfully administering the program since 2000 and now represents over 140 pharmaceutical and consumer health products brand-owners (see the final page for a full listing). While these programs are regulated in British Columbia and Manitoba similar programs are run on a voluntary basis in other provinces and territories The program has been extremely successful in gaining the support and participation of community pharmacies.
    [Show full text]
  • Appendix B - Product Name Sorted by Applicant
    JUNE 2021 - APPROVED DRUG PRODUCT LIST B - 1 APPENDIX B - PRODUCT NAME SORTED BY APPLICANT ** 3 ** 3D IMAGING DRUG * 3D IMAGING DRUG DESIGN AND DEVELOPMENT LLC AMMONIA N 13, AMMONIA N-13 FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18 SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18 3M * 3M CO PERIDEX, CHLORHEXIDINE GLUCONATE * 3M HEALTH CARE INC AVAGARD, ALCOHOL (OTC) DURAPREP, IODINE POVACRYLEX (OTC) 3M HEALTH CARE * 3M HEALTH CARE INFECTION PREVENTION DIV SOLUPREP, CHLORHEXIDINE GLUCONATE (OTC) ** 6 ** 60 DEGREES PHARMS * 60 DEGREES PHARMACEUTICALS LLC ARAKODA, TAFENOQUINE SUCCINATE ** A ** AAA USA INC * ADVANCED ACCELERATOR APPLICATIONS USA INC LUTATHERA, LUTETIUM DOTATATE LU-177 NETSPOT, GALLIUM DOTATATE GA-68 AAIPHARMA LLC * AAIPHARMA LLC AZASAN, AZATHIOPRINE ABBVIE * ABBVIE INC ANDROGEL, TESTOSTERONE CYCLOSPORINE, CYCLOSPORINE DEPAKOTE ER, DIVALPROEX SODIUM DEPAKOTE, DIVALPROEX SODIUM GENGRAF, CYCLOSPORINE K-TAB, POTASSIUM CHLORIDE KALETRA, LOPINAVIR NIASPAN, NIACIN NIMBEX PRESERVATIVE FREE, CISATRACURIUM BESYLATE NIMBEX, CISATRACURIUM BESYLATE NORVIR, RITONAVIR SYNTHROID, LEVOTHYROXINE SODIUM ** TARKA, TRANDOLAPRIL TRICOR, FENOFIBRATE TRILIPIX, CHOLINE FENOFIBRATE ULTANE, SEVOFLURANE ZEMPLAR, PARICALCITOL ABBVIE ENDOCRINE * ABBVIE ENDOCRINE INC LUPANETA PACK, LEUPROLIDE ACETATE ABBVIE ENDOCRINE INC * ABBVIE ENDOCRINE INC LUPRON DEPOT, LEUPROLIDE ACETATE LUPRON DEPOT-PED KIT, LEUPROLIDE ACETATE ABBVIE INC * ABBVIE INC DUOPA, CARBIDOPA MAVYRET, GLECAPREVIR NORVIR, RITONAVIR ORIAHNN (COPACKAGED), ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE
    [Show full text]
  • Pharmaceuticals and Product Stewardship
    Pharmaceuticals and Product Stewardship Sierra Fletcher Product Stewardship Institute April 29, 2011 Who is the Product Stewardship Institute? . Non‐profit founded in 2000 . Membership 47 States 200+ Local governments 70+ Corporate, Organizational, Academic & Non‐U.S. Government Partners . Board of Directors: 7 states, 4 local agencies • Multi‐stakeholder product stewardship network April 29, 2011 2 Product Stewardship : councils & other groups promoting product stewardship April 29, 2011 3 Why do we need it? The average American throws away 1,600 pounds of trash each year That means by age 25 you’ve thrown away 40,000 pounds Different Kinds of Toxicity April 29, 2011 5 We are all responsible… Shared Responsibility Manufacturers Retailers Other Businesses Government Consumers April 29, 2011 6 PSI Principles of Product Stewardship 1. Cost internalization 2. Shared responsibility (manufacturers have greatest role) 3. Lifecycle costs 4. Performance goals 5. Flexibility for producers o Basic building blocks of product stewardship programs o Developed by PSI in 2001 o Endorsements: National League of Cities, Environmental Council of States, Solid Waste Association of North America, and many other organizations April 29, 2011 7 Examples of Product Stewardship • Government oversees the implementation of product stewardship laws. • Phone book industry offers the public the chance to opt‐out of receiving phone books. • Manufacturer removes toxic substance from product or manufacturing process. • Retailers collect products for recycling. • Rechargeable battery manufacturers provide collection boxes to recycle their product.* • Fluorescent lamp manufacturers implement recycling program in Maine.* April 29, 2011 8 Extended producer responsibility Extended Producer Responsibility (EPR), a central tenet of product stewardship, is a policy approach in which the producer’s responsibility for their product extends to the post‐consumer management of that product and its packaging.
    [Show full text]
  • Associate Member Companies As of October 15, 2012 A&D Medical
    Associate Member Companies as of October 15, 2012 A&D Medical ‐ LifeSource Acosta Sales and Marketing Company San Jose CA Brea CA http://www.LifeSourceOnline.com http://www.acosta.com Aaron Industries Inc. Actavis Clinton SC Morristown NJ http://www.aaronindustriesinc.com http://www.actavis.us Abbott Diabetes Care Active International, Inc. Alameda CA Pearl River NY http://www.abbottdiabetescare.com http://www.activeinternational.com Abbott Medical Optics, Inc. Aderans Hair Goods Lake Forest CA Beverly Hills CA http://www.amo‐inc.com http://www.reneofparis.com Abbott Nutrition ADFLOW Health Networks Columbus OH Doylestown PA http://www.ross.com http://www.adflownetworks.com Abbott ‐ Pharmaceutical Products Division Adheris, Inc. Abbott Park IL Burlington MA http://www.abbott.com http://www.adheris.com Absolute AR Advance Sales Group, Inc. Fort Worth TX Commerce CA http://www.pdxinc.com http://www.advancesalesgroup.com Accera, Inc. Advanced Beauty, Inc. Broomfield CO Dallas TX http://www.accerapharma.com http://www.bodycology.us Accord Healthcare Advanced Marketing & Sales, Inc. Durham NC Vernon Hills IL http://accord‐healthcare.com http://www.amsrep.com Acon Laboratories Inc. Advanced Vision Research San Diego CA Lake Forest IL http://www.aconlabs.com http://www.theratears.com Associate Member Companies as of October 15, 2012 Advantage Consumer Healthcare LLC Alex Orthopedic, Inc. Pittsburgh PA Grand Prairie TX http://www.advantagechc.com http://www.alexorthopedic.com Advantage Sales and Marketing The Alkalol Company Irvine CA Boston MA http://www.asmnet.com http://www.alkalolcompany.com Adwin USA, Inc., Dba COHBE Allergan Inc. Carson CA Irvine CA http://www.cohbe.com http://www.allergan.com Affinnova Allison Medical Inc.
    [Show full text]
  • American Foundation for Pharmaceutical Education Box: 8
    Ronald Reagan Presidential Library Digital Library Collections This is a PDF of a folder from our textual collections. Collection: Turner, Carlton E.: Files Folder Title: American Foundation for Pharmaceutical Education Box: 8 To see more digitized collections visit: https://reaganlibrary.gov/archives/digital-library To see all Ronald Reagan Presidential Library inventories visit: https://reaganlibrary.gov/document-collection Contact a reference archivist at: [email protected] Citation Guidelines: https://reaganlibrary.gov/citing National Archives Catalogue: https://catalog.archives.gov/ .. i ! f;c~~~ I I ,J I American Foundation For Pharmaceutical Education I OIRECTOF)S RADBURN PLAZA BUILDING 14-25 PLAZA ROAD, FAIR LAWN, N.J. 07410 Ronald J. Brenner. Ph.D. (201) 791-5192 INCORPORATED 1942 Cytogen Corpnr~lion William H. Campbell. Ph .D. March 3, 1986 Unfrersity of Washington Herbert 5. Carlin OFFICERS The New York Hospital Peter G. Tombros. Chaimratt of Board Paul N. Clark Abbott Wboralories Ronald J. Brenner. Ph.D .. Via Clwimum of Board L. Jack R. Cole. Ph.D. Robert Hanson, Treasurer William F. Weigel. Coumel and S(•aetary Uni\·ersity of Ariwna Thomas M. Collins Carlton E. Turner, Ph.D. E. PresitJ,,,u SmithK/i11e Beckman Corpora/ion Richard Faust. Ph.D .. Herbert J. Conrad Deputy Assistant to the President Hoffmann-Lo Roche Inc. for Drug Abuse Policy John W. Culligan American Home Products Corporation The White House Angele C. D"Angelo Washington, DC 20001 St. John's University Robert A . Dube Owens-Illinois Dear Carlton, Frederick M. Eckel 1he University of Nonh Carolina George W. Eckelmann Thanks for your kind note just before the holidays ..
    [Show full text]
  • Discontinued Items Ct
    Discontinued Items ct Smith # Sz Description NDC/UPC Manufacturer 785006 1ct Paliperidone ER Tab 3mg 30ct 30591369330 Actavis/Teva 816686 1ct Irbesartan Tab 75mg 90ct 36233204190 Alembic Pharma 816652 1ct Irbesartan Tab 150mg 500ct 36233204271 Alembic Pharma 816660 1ct Irbesartan Tab 300mg 500ct 36233204371 Alembic Pharma 816678 1ct Irbesartan Tab 300mg 90ct 36233204390 Alembic Pharma 767558 1ct Valsartan Tab 40mg 90ct 36233204490 Alembic Pharma 767574 1ct Valsartan Tab 80mg 500ct 36233204571 Alembic Pharma 860023 1ct Econazole Nitrate Cream 1% 15gm 34778154372 Alvogen, Inc. 860031 1ct Econazole Nitrate Cream 1% 30gm 34778154373 Alvogen, Inc. 689729 1ct BV Pain Rel Caplets XS 2x100ct 34948334120 Basic Drugs 666172 1ct Dulco Gas Max Str Tangy Citrus 18ct 68142102611 Chattem Drug 195115 1ct Halls C Drops Sp/Mint Bag 30’s 31254662742 Dot Foods, Inc. 330019 1ct JJ Sport Tape 1 1/2x10yd 38137007902 Dot Foods, Inc. 381251 1ct Halls Defense Vit C S/Bry 20x9 Loz 31254605091 Dot Foods, Inc. 863753 1ct Fluocinonide Gel .05% 15gm 30713080315 G&W Labs 752238 1ct Aspirin Child Chew 81mg 3x36ct 30536100862 Major/Rugby 211169 1ct Reguloid S/Free Powder 10oz 30536188179 Major/Rugby 251884 1ct Lorazepam Tab .5mg 500ct 30378232105 Mylan Pharma 256982 1ct Lorazepam Tab 1mg 100ct 30378245701 Mylan Pharma 250662 1ct Lorazepam Tab 1mg 1000ct 30378245710 Mylan Pharma 259416 1ct Lorazepam Tab 2mg 100ct 30378277701 Mylan Pharma 246934 1ct Lorazepam Tab 2mg 500ct 30378277705 Mylan Pharma 740175 1ct Finasteride Tab 5mg 90ct 30378503677 Mylan Pharma 542753 1ct Levocetirizine/Dihydr Tab 5mg 300ct 34580259487 Perrigo Pharma 319574 1ct Colocort Enema 60ml 30574202001 Perrigo Pharma 687962 1ct Klor-Con M20 Tab ER 20MEQ 1000ct 36675819010 Sandoz Inc.
    [Show full text]
  • Product Stewardship Financing Models: a Look at the Post-Consumer Pharmaceutical Stewardship Association
    Product Stewardship Financing Models: A Look at the Post-Consumer Pharmaceutical Stewardship Association Type of Brand-owner funded take-back program (mandatory in BC and Manitoba). Program: Pharmaceuticals and natural health products, including prescription drugs, nonprescription Scope: medicines and natural health products such as herbal products, mineral and vitamin supplements (accepted in household quantities). In 1997, the B.C. Waste Management Act – Post Consumer Residual Stewardship, required all Status: brand-owners of pharmaceutical products to be responsible for their products’ end-of-life disposal. Starting in 2000, PCPSA began managing the stewardship plan with the Medications Return Program. The Recycling Regulation (B.C. Reg 449/2004) has now replaced the previous regulation. Overview Unused medications are a health and safety hazard when stored in patients’ homes. They can also damage the natural environment when incorrectly used or disposed of. The Post-Consumer Pharmaceutical Stewardship Association (PCPSA) is a non-profit organization that directly administers the Medications Return Program through funding from pharmaceutical and consumer health products members. PCPSA was established by the industry to comply with British Columbia’s Waste Management Act, a law intended to reduce the environmental and public health risks associated with consumer goods, including leftover medications. The act requires producers to establish a system to safely collect and dispose of the public’s unused medications. PCPSA has been successfully administering the program since 2000 and now represents over 140 pharmaceutical and consumer health products brand-owners (see the final page for a full listing). While these programs are regulated in British Columbia and Manitoba similar programs are run on a voluntary basis in other provinces and territories The program has been extremely successful in gaining the support and participation of community pharmacies.
    [Show full text]
  • Participating Vendor List October 2020
    Participating Vendor List October 2020 Contracted Vendor Additions Contracted Vendor Deletions Accord BioPharma, Inc. ACADIA Pharmaceuticals Inc. Adhezion Biomedical, LLC AdvancePierre Foods, Inc Automated HealthCare Solutions, LLC Allcare, Inc. Balance Vibration Technologies, Inc. Alliance Tech Medical, Inc. CitraPac, Inc. Bon Chef, Inc DuBois Chemicals, Inc. Bryton Corporation Exalt Printing Solutions, LLC Cardinal International Healthcare Information LLC Carter- Hoffmann Corp. Hershey Creamery Company Cosmed USA Kay Kare LLC Dinex International, Inc. Link America, LLC Faxitron Bioptics Merchant Advocate, LLC GE-OEC Medical Systems, Inc. Plastic Film, LLC Medcomflow SDI Labs Inc Medic Vision Imaging Solutions Ltd Sugar Foods Corporation National Recall Alert Center Sunfarm Food Service Pharm3r LLC Syracuse Banana Co., Inc. Sapheneia V. Marchese Inc. Stanley Elevator Company, Inc. Vari Sales Corporation T2 Biosystems Ziehm Imaging Inc Premier, Inc. 10/19/2020 Page 1 NOTE: -Contracted vendors are in plain text. -Vendors who have submitted bids are highlighted in YELLOW. Name Top Parent Name Ownership Stock Symbol Exchange 2G Medical, LLC. 2G Medical, LLC. Private 3 West Medical 3 West Medical Private 3M Company 3M Company Public MMM NYSE 3M Health Information Systems 3M Company Public MMM NYSE 3T Medical Systems LLC 3T Medical Systems LLC Private 410 Medical, Inc 410 Medical, Inc 4WEB Medical, Inc. 4WEB Medical, Inc. Private 6P International LLC 6P International LLC Private 7D Surgical 7D Surgical 8K Miles Software Services / Serj Solutions 8K Miles Software Services / Serj Solutions A M Communications Solutions Inc. A M Communications Solutions Inc. Private A Management Group A Management Group Private A&A Produce Co. A&A Produce Co. A&D Medical A&D Medical Private A&E Enterprises of Louisiana, LLC A&E Enterprises of Louisiana, LLC A&E Medical Corporation A&E Medical Corporation Private A-1 International, Inc.
    [Show full text]